A comprehensive study of antithrombin deficiency in a large cohort of Chinese thrombophilia pedigrees: uncovering 4 SERPINC1 pathogenic variants merely impaired progressive activities
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2025.04.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Changming Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; State Key Laboratory of Medical…. Hauptthemen laut MEDLINE: Antithrombin III, Antithrombin III Deficiency, Blood Coagulation, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Hospital Development Center, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Congenital antithrombin (AT) deficiency, primarily caused by variants in SERPINC1, is associated with a high risk of venous thromboembolism. Existing diagnostic procedures, mainly based on functional assays, may miss certain pathogenic variants. OBJECTIVES: To comprehensively evaluate AT deficiency prevalence in the Chinese thrombophilia population and identify SERPINC1 variants overlooked by traditional diagnostic procedures. METHODS: We conducted functional assays and genetic analysis simultaneously in 842 Chinese thrombophilia pedigrees. Supplementary functional assays (progressive assay and thrombin generation test) and in vitro enzymatic assays were used to detect AT defects, assess thrombotic risk, and investigate the pathogenic mechanisms of selected variants. RESULTS: We identified 72 cases with decreased AT activity (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai…
- Department of Clinical Hematology and Osology, Shanghai Center of Clinical Laboratory, Shanghai, China.
- Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Collaborative Innovation Center of Hematology, Shanghai Jiaotong University School of Medicine, Shang…
- Department of Molecular Biology, Shanghai Center for Clinical Laboratory, Shanghai, China. Electronic address: huxiaobo@vip.sina.com.
Förderung
- Shanghai Municipal Hospital Development Center
- National Natural Science Foundation of China
Zitieren
APA
Chen, C., Wu, X., Li, L., Xiang, Y., Zhang, H., Song, Y., Ding, Q., Wang, X., Hu, X., & Dai, J. (2025). A comprehensive study of antithrombin deficiency in a large cohort of Chinese thrombophilia pedigrees: uncovering 4 SERPINC1 pathogenic variants merely impaired progressive activities. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.04.022
Vancouver
Chen C, Wu X, Li L, Xiang Y, Zhang H, Song Y, et al. A comprehensive study of antithrombin deficiency in a large cohort of Chinese thrombophilia pedigrees: uncovering 4 SERPINC1 pathogenic variants merely impaired progressive activities. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.04.022
BibTeX
@article{Chen2025,
author = {Chen, Changming and Wu, Xi and Li, Lei and Xiang, Yue and Zhang, Huayang and Song, Ying and Ding, Qiulan and Wang, Xuefeng and Hu, Xiaobo and Dai, Jing},
title = {A comprehensive study of antithrombin deficiency in a large cohort of Chinese thrombophilia pedigrees: uncovering 4 SERPINC1 pathogenic variants merely impaired progressive activities},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2025.04.022}
}
EUVIMED